Pacific Biosciences of California, Inc. (PACB)
1.385
-0.06
(-4.48%)
USD |
NASDAQ |
Jun 08, 15:36
Pacific Biosciences of California EPS Diluted (Quarterly) : -0.0271 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Phibro Animal Health Corp. | 0.5854 |
| Illumina, Inc. | 0.8701 |
| GE Healthcare Technologies, Inc. | 0.8512 |
| Revvity, Inc. | 0.364 |
| Bruker Corp. | 0.0229 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.275M |
| Revenue (Quarterly) | 37.18M |
| Total Expenses (Quarterly) | 45.45M |
| Enterprise Value | 877.61M |
| Gross Profit Margin (Quarterly) | 32.30% |
| Profit Margin (Quarterly) | -22.26% |
| Earnings Yield | -30.82% |
| Normalized Earnings Yield | -24.34 |